1. Home
  2. DCI vs BIO Comparison

DCI vs BIO Comparison

Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

HOLD

Current Price

$102.23

Market Cap

11.7B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$312.40

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCI
BIO
Founded
1915
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
8.7B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
DCI
BIO
Price
$102.23
$312.40
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$98.00
$358.50
AVG Volume (30 Days)
628.2K
184.0K
Earning Date
02-26-2026
02-12-2026
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
3.21
N/A
Revenue
$3,726,200,000.00
$2,557,500,000.00
Revenue This Year
$4.69
$1.62
Revenue Next Year
$4.71
$2.26
P/E Ratio
$31.15
N/A
Revenue Growth
2.37
N/A
52 Week Low
$57.45
$211.43
52 Week High
$101.61
$373.69

Technical Indicators

Market Signals
Indicator
DCI
BIO
Relative Strength Index (RSI) 73.62 47.12
Support Level $99.29 $306.52
Resistance Level $101.48 $328.56
Average True Range (ATR) 1.77 9.16
MACD 0.90 -0.38
Stochastic Oscillator 96.52 40.11

Price Performance

Historical Comparison
DCI
BIO

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: